(888) 645-1617
Drugwatch.com Author

Jen Juneau Content Writer

Jen graduated from the University of Central Florida in 2007 with a Bachelor of Arts in English – technical communication and a minor in magazine journalism. She has more than six years of professional writing experience, having worked for Publix Super Markets as a training developer, a marketing company as a web writer, and a software company as a technical writer. At these companies, she wrote and edited a variety of content, including but not limited to user guides, job-class-training materials, software release notes, blogs, articles, video scripts and static web content.

Jen has a passion for sound communication, flawless grammar and epitomic customer service, and believes highly in the old adage “quality over quantity.” In her spare time, she enjoys writing for various online novelty publications and editing a myriad of content, including children’s and health-and-fitness books. She can often be found running, baking, playing with her cat, watching old movies, debating board-game rules and listening to long-since-forgotten ‘90s one-hit wonders and claiming they’re the best thing since sliced bread. She’s marrying her best friend on 12/13/14.

Having grown up with a disabled father, Jen acquired a solid understanding of the importance of quality health care from an early age, and loves educating others about drugs and medical devices that can have a huge impact on their quality of life; she can’t imagine a better way to feel fulfilled. Feel free to forward any questions, comments or article ideas to her at jjuneau@drugwatch.com.


FDA News & Recalls 3.13.14 Injection Needle

FDA Approves Aveed Testosterone Product, with Restrictions

The U.S. Food and Drug Administration (FDA) this month approved the testosterone replacement therapy...

Learn More
Health & Medical Conditions 10.08.13 Nurse taking blood from a man

Clinical Trials: What You Don’t Know Can Hurt You

Since the mid-twentieth century, clinical trials employing human volunteers have drastically altered the landscape of modern medicine, improving our...

Learn More
Dangerous Prescription Drugs 7.23.13 illustration of red blood cells

Projected Growth in Blood Thinner Market Could Put More People at Risk

Pharmaceutical forecasters say sales of blood thinners will grow higher than any other prescription drug class over the next six years, according to...

Learn More
Current Litigation & Lawsuit News 7.08.13 Endo AMS Logo and gavel

Endo’s AMS Unit Settles Lawsuits for $54.5M; First Federal Mesh Trial Begins

As the first federal trial about the liability tied to transvaginal mesh begins today, one manufacturer announced it settled a number of mesh lawsuits. American...

Learn More
FDA News & Recalls 6.13.13 Avandia drug bottle

FDA Panel Votes in Favor of Loosening Avandia Restrictions

A panel of U.S. Food and Drug Administration (FDA) advisers voted to give the public more access to Avandia,...

Learn More
Dangerous Prescription Drugs 5.30.13 Lipitor box and pills with the word "diabetes" under a magnifying glass

Lipitor and Other High-Potency Statins May Increase Diabetes Risk

Several high-potency statins, a class of widely prescribed cholesterol-lowering drugs, may increase the risk for developing type 2 diabetes, according...

Learn More